This proposal is a renewal application for a second 5-year National Research Service Award Institutional Research Grant to support a training program in HIV Epidemiology and Prevention Sciences at the Johns Hopkins Bloomberg School of Public Health (BSPH) and the Johns Hopkins School of Medicine (SOM), entitled the ?Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program.? The program is led by Director Chris Beyrer MD, MPH, and Deputy Director Shruti Mehta PhD, MPH. We are requesting support for 3 pre- and 4 post-doctoral trainees, which represents an increase of 2 post-doctoral trainees from our prior funding period. The program mission is to train pre-doctoral students and post-doctoral fellows to become leaders at the forefront of highest priority HIV research with advanced competencies and state-of-the-art skills in three training tracks: HIV Epidemiology and Implementation Science Methods including training in (1) Populations and Study Designs, including identification, recruitment and retention; (2) Measurement issues in HIV populations, including innovative methods for surveillance, recruitment, estimation of HIV prevalence and incidence, (3) Inference techniques, including modern analytical methods for causal inference and mathematical modeling; and (4) Synthesis and Implementation of research findings to public health practice; HIV Clinical and Laboratory Sciences including training in (1) the epidemiology, prevention and treatment of major co- infections with HIV including hepatitis C virus (HCV) infection and tuberculosis; (2) epidemiology and pathogenesis of HIV and age-associated co-morbidities; and (3) Measurement and use of genetic, virologic and immunologic factors that can inform our knowledge of the pathogenesis and transmission of HIV; HIV Prevention Sciences including how to prevent and reduce the prevalence and incidence of HIV through training in (1) Design and Analysis of HIV biomedical, behavioral and combination prevention trials, including treatment as prevention research (TasP), oral and topical PrEP trials, HIV vaccine trials and passive immune-therapy trials, and (2) Community-based population-level approaches to HIV prevention and control beyond individual behavior change. Our program, which is fully integrated through the JHU Center for AIDS Research (CFAR) has resulted in a rich and interactive environment for trainees working in HIV augmented by the exceptionally innovative, productive and collaborative HIV research conducted by epidemiological, clinical, prevention and implementation scientists throughout Johns Hopkins BSPH, and SOM.

Public Health Relevance

This proposal is a renewal application for a second 5-year National Research Service Award Institutional Research Grant to support a training program in HIV Epidemiology and Prevention Sciences at the Johns Hopkins Bloomberg School of Public Health (BSPH) and the Johns Hopkins School of Medicine (SOM) entitled the ?Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program.? We are requesting support for 3 pre- and 4 post-doctoral trainees, who will be trained in three parallel training tracks: HIV Epidemiology and Implementation Science Methods; HIV Clinical and Laboratory Sciences; and HIV Prevention Sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
2T32AI102623-06
Application #
9407372
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Mckaig, Rosemary G
Project Start
2013-06-01
Project End
2023-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Solomon, S S; Sulkowski, M S; Amrose, P et al. (2018) Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). J Viral Hepat 25:37-46
Smith, M K; Graham, M; Latkin, C A et al. (2018) Quantifying potentially infectious sharing patterns among people who inject drugs in Baltimore, USA. Epidemiol Infect 146:1845-1853
Raifman, Julia; Lam, Felix; Keller, Janeen Madan et al. (2018) How well are aid agencies evaluating programs? An assessment of the quality of global health evaluations. J Dev Effect 10:277-289
Canan, Chelsea E; Chander, Geetanjali; Monroe, Anne K et al. (2018) High-Risk Prescription Opioid Use Among People Living With HIV. J Acquir Immune Defic Syndr 78:283-290
Raifman, Julia; Beyrer, Chris; Arrington-Sanders, Renata (2018) HIV Education and Sexual Risk Behaviors Among Young Men Who Have Sex with Men. LGBT Health 5:131-138
Calkins, Keri L; Canan, Chelsea E; Moore, Richard D et al. (2018) An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use. BMC Med Res Methodol 18:27
Hirasen, Kamban; Evans, Denise; Maskew, Mhairi et al. (2018) The right combination - treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa. Clin Epidemiol 10:17-29
Sacamano, Paul; Krawczyk, Noa; Latkin, Carl (2018) Emergency Department Visits in a Cohort of Persons with Substance Use: Incorporating the Role of Social Networks. Subst Use Misuse 53:2265-2269
Patel, Eshan U; Solomon, Sunil S; Mcfall, Allison M et al. (2018) Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India. Int J Drug Policy 57:51-60
Lee, Alice J; Montgomery, Madeline C; Patel, Rupa R et al. (2018) Improving Insurance and Health Care Systems to Ensure Better Access to Sexually Transmitted Disease Testing and Prevention. Sex Transm Dis 45:283-286

Showing the most recent 10 out of 58 publications